NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells
Open Access
- 5 August 2008
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (31) , 10883-10888
- https://doi.org/10.1073/pnas.0805186105
Abstract
BAFF-R-dependent activation of the alternative NF-κB pathway plays an essential role in mature B cell survival. Mutations leading to overexpression of NIK and deletion of the TRAF3 gene are implicated in human multiple myeloma. We show that overexpression of NIK in mouse B lymphocytes amplifies alternative NF-κB activation and peripheral B cell numbers in a BAFF-R-dependent manner, whereas uncoupling NIK from TRAF3-mediated control causes maximal p100 processing and dramatic hyperplasia of BAFF-R-independent B cells. NIK controls alternative NF-κB signaling by increasing the protein levels of its negative regulator TRAF3 in a dose-dependent fashion. This mechanism keeps NIK protein levels below detection even when they cause B cell hyperplasia, so that contributions of NIK to B cell pathologies can easily be overlooked.Keywords
This publication has 30 references indexed in Scilit:
- Control of canonical NF-κB activation through the NIK–IKK complex pathwayProceedings of the National Academy of Sciences, 2008
- TRAF2 and TRAF3 Signal Adapters Act Cooperatively to Control the Maturation and Survival Signals Delivered to B Cells by the BAFF ReceptorImmunity, 2008
- Bruton’s Tyrosine Kinase Mediates NF-κB Activation and B Cell Survival by B Cell-Activating Factor Receptor of the TNF-R FamilyThe Journal of Immunology, 2007
- Tumor Necrosis Factor Receptor-Associated Factor 3 Is a Critical Regulator of B Cell Homeostasis in Secondary Lymphoid OrgansImmunity, 2007
- Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple MyelomaCancer Cell, 2007
- Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple MyelomaCancer Cell, 2007
- B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signalingCurrent Opinion in Immunology, 2007
- Control of B Lymphocyte Apoptosis by the Transcription Factor NF-κBImmunity, 2006
- BAFF controls B cell metabolic fitness through a PKCβ- and Akt-dependent mechanismThe Journal of Experimental Medicine, 2006
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002